Articles by Donald Weed, MD
Radiation for Chemo-Sensitization: A Phase II Trial of Cetuximab and Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
ByVivek N. Patel, MD,Felix M. Chinea, MD,Deukwoo Kwon, PhD,Gustavo Fernandez, MD,Hanmath J Neboori, MD,Michael A. Samuels, MD,Laura M. Freedman, MD,Nagy M. Elsayad,Donald Weed, MD,Elizabeth Franzmann, MD,Chukwuemeka V. Ikpeazu, MD, PhD,Matthew C. Abramowitz, MD This study evaluates low dose radiotherapy in combination with docetaxel and cetuximab in patients with recurrent, unresectable squamous cell carcinoma of the head and neck initially treated with definitive chemo-radiation therapy.
